HEADER TRANSCRIPTION 14-MAR-07 2P54
TITLE A CRYSTAL STRUCTURE OF PPAR ALPHA BOUND WITH SRC1 PEPTIDE AND GW735
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: PPAR ALPHA;
COMPND 5 SYNONYM: PPAR-ALPHA;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1;
COMPND 9 CHAIN: B;
COMPND 10 FRAGMENT: SRC1 PEPTIDE;
COMPND 11 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160,
COMPND 12 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52;
COMPND 13 EC: 2.3.1.48;
COMPND 14 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PPARA, NR1C1, PPAR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 MOL_ID: 2;
SOURCE 9 SYNTHETIC: YES;
SOURCE 10 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS
KEYWDS PPAR ALPHA GW735 SRC1 AGONIST HDLC, TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR R.X.XU,H.E.XU,M.L.SIERRA,V.G.MONTANA,M.H.LAMBERT,P.M.PIANETTI
REVDAT 4 03-APR-24 2P54 1 REMARK
REVDAT 3 21-FEB-24 2P54 1 REMARK SEQADV
REVDAT 2 24-FEB-09 2P54 1 VERSN
REVDAT 1 24-APR-07 2P54 0
JRNL AUTH M.L.SIERRA,V.BENETON,A.B.BOULLAY,T.BOYER,A.BREWSTER,
JRNL AUTH 2 F.DONCHE,M.C.FOREST,M.H.FOUCHET,F.J.GELLIBERT,D.A.GRILLOT,
JRNL AUTH 3 M.H.LAMBERT,A.LAROZE,C.L.GRUMELEC,J.M.LINGET,V.G.MONTANA,
JRNL AUTH 4 V.L.NGUYEN,E.NICODEME,V.PATEL,A.PENFORNIS,O.PINEAU,D.POHIN,
JRNL AUTH 5 F.POTVAIN,G.PAULAIN,C.B.RUAULT,M.SAUNDERS,J.TOUM,H.E.XU,
JRNL AUTH 6 R.X.XU,P.M.PIANETTI
JRNL TITL SUBSTITUTED 2-[(4-AMINOMETHYL)PHENOXY]-2-METHYLPROPIONIC
JRNL TITL 2 ACID PPAR AGONISTS. 1.DISCOVERY OF A NOVEL SERIES OF POTENT
JRNL TITL 3 HDLC RAISING AGENTS.
JRNL REF J.MED.CHEM. V. 50 685 2007
JRNL REFN ISSN 0022-2623
JRNL PMID 17243659
JRNL DOI 10.1021/JM058056X
REMARK 2
REMARK 2 RESOLUTION. 1.79 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5
REMARK 3 NUMBER OF REFLECTIONS : 29552
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.204
REMARK 3 FREE R VALUE : 0.227
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 1761
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2196
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 33
REMARK 3 SOLVENT ATOMS : 268
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 3.20
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.00
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.01500
REMARK 3 B22 (A**2) : 0.01000
REMARK 3 B33 (A**2) : 0.00500
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.005
REMARK 3 BOND ANGLES (DEGREES) : 1.287
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: ML
REMARK 4
REMARK 4 2P54 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAR-07.
REMARK 100 THE DEPOSITION ID IS D_1000041977.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 05-JUL-01
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00
REMARK 200 MONOCHROMATOR : SI 111 CHANNEL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30145
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.240
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0
REMARK 200 DATA REDUNDANCY : 7.100
REMARK 200 R MERGE (I) : 0.04500
REMARK 200 R SYM (I) : 0.04500
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 39.4500
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86
REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8
REMARK 200 DATA REDUNDANCY IN SHELL : 7.50
REMARK 200 R MERGE FOR SHELL (I) : 0.35000
REMARK 200 R SYM FOR SHELL (I) : 0.35000
REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: APO PPAR ALPHA
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.52
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 7% PEG 3350, 200 MM NAF, 12% 2,5
REMARK 280 -HEXANEDIOL, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE
REMARK 280 295K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 30.63150
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.76750
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.63150
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.76750
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASP A 202 CG OD1 OD2
REMARK 470 ASN A 235 CG OD1 ND2
REMARK 470 ASN A 261 CG OD1 ND2
REMARK 470 ASN A 393 CG OD1 ND2
REMARK 470 TYR A 468 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 ARG B 686 CG CD NE CZ NH1 NH2
REMARK 470 LYS B 688 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 392 -64.27 -91.80
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 735 A 469
DBREF 2P54 A 202 468 UNP Q07869 PPARA_HUMAN 202 468
DBREF 2P54 B 686 696 UNP Q15788 NCOA1_HUMAN 686 696
SEQADV 2P54 ALA B 685 UNP Q15788 CLONING ARTIFACT
SEQRES 1 A 267 ASP LEU LYS SER LEU ALA LYS ARG ILE TYR GLU ALA TYR
SEQRES 2 A 267 LEU LYS ASN PHE ASN MET ASN LYS VAL LYS ALA ARG VAL
SEQRES 3 A 267 ILE LEU SER GLY LYS ALA SER ASN ASN PRO PRO PHE VAL
SEQRES 4 A 267 ILE HIS ASP MET GLU THR LEU CYS MET ALA GLU LYS THR
SEQRES 5 A 267 LEU VAL ALA LYS LEU VAL ALA ASN GLY ILE GLN ASN LYS
SEQRES 6 A 267 GLU ALA GLU VAL ARG ILE PHE HIS CYS CYS GLN CYS THR
SEQRES 7 A 267 SER VAL GLU THR VAL THR GLU LEU THR GLU PHE ALA LYS
SEQRES 8 A 267 ALA ILE PRO GLY PHE ALA ASN LEU ASP LEU ASN ASP GLN
SEQRES 9 A 267 VAL THR LEU LEU LYS TYR GLY VAL TYR GLU ALA ILE PHE
SEQRES 10 A 267 ALA MET LEU SER SER VAL MET ASN LYS ASP GLY MET LEU
SEQRES 11 A 267 VAL ALA TYR GLY ASN GLY PHE ILE THR ARG GLU PHE LEU
SEQRES 12 A 267 LYS SER LEU ARG LYS PRO PHE CYS ASP ILE MET GLU PRO
SEQRES 13 A 267 LYS PHE ASP PHE ALA MET LYS PHE ASN ALA LEU GLU LEU
SEQRES 14 A 267 ASP ASP SER ASP ILE SER LEU PHE VAL ALA ALA ILE ILE
SEQRES 15 A 267 CYS CYS GLY ASP ARG PRO GLY LEU LEU ASN VAL GLY HIS
SEQRES 16 A 267 ILE GLU LYS MET GLN GLU GLY ILE VAL HIS VAL LEU ARG
SEQRES 17 A 267 LEU HIS LEU GLN SER ASN HIS PRO ASP ASP ILE PHE LEU
SEQRES 18 A 267 PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN
SEQRES 19 A 267 LEU VAL THR GLU HIS ALA GLN LEU VAL GLN ILE ILE LYS
SEQRES 20 A 267 LYS THR GLU SER ASP ALA ALA LEU HIS PRO LEU LEU GLN
SEQRES 21 A 267 GLU ILE TYR ARG ASP MET TYR
SEQRES 1 B 12 ALA ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU
HET 735 A 469 53
HETNAM 735 2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)
HETNAM 2 735 PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)
HETNAM 3 735 AMINO]METHYL}PHENOXY)PROPANOIC ACID
FORMUL 3 735 C23 H21 F3 N2 O4 S
FORMUL 4 HOH *268(H2 O)
HELIX 1 1 SER A 205 PHE A 218 1 14
HELIX 2 2 ASN A 221 SER A 230 1 10
HELIX 3 3 ASP A 243 VAL A 255 1 13
HELIX 4 4 ALA A 256 ALA A 260 5 5
HELIX 5 5 GLY A 262 LYS A 266 5 5
HELIX 6 6 GLU A 267 ALA A 293 1 27
HELIX 7 7 GLY A 296 LEU A 300 5 5
HELIX 8 8 ASP A 301 SER A 322 1 22
HELIX 9 9 ARG A 341 LEU A 347 1 7
HELIX 10 10 PRO A 350 ILE A 354 5 5
HELIX 11 11 MET A 355 ALA A 367 1 13
HELIX 12 12 ASP A 371 CYS A 384 1 14
HELIX 13 13 ASN A 393 HIS A 416 1 24
HELIX 14 14 PHE A 421 GLU A 451 1 31
HELIX 15 15 HIS A 457 ARG A 465 1 9
HELIX 16 16 HIS B 687 GLU B 696 1 10
SHEET 1 A 4 PHE A 239 ILE A 241 0
SHEET 2 A 4 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241
SHEET 3 A 4 GLY A 329 VAL A 332 -1 N VAL A 332 O GLY A 337
SHEET 4 A 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329
CISPEP 1 LYS A 349 PRO A 350 0 -0.16
SITE 1 AC1 16 ILE A 241 GLU A 251 VAL A 255 PHE A 273
SITE 2 AC1 16 CYS A 276 GLN A 277 THR A 279 SER A 280
SITE 3 AC1 16 TYR A 314 VAL A 332 ILE A 354 MET A 355
SITE 4 AC1 16 HIS A 440 LEU A 460 TYR A 464 HOH A 476
CRYST1 61.263 103.535 49.850 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016323 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009659 0.000000 0.00000
SCALE3 0.000000 0.000000 0.020060 0.00000